Research and Markets: A Chance to Gain Knowledge of Assays and Assay Development That Normally Accumulate Over Many Years of Personal Experience with Laboratory Assay Technology.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c41997) has announced the addition of Assay Development and Technologies, 2nd Edition to their offering. 'Assay Development& Technologies, 2nd Edition' offers essential information to speed up and simplify assay development. This professional development guide thoroughly evaluates the capabilities, strengths, weaknesses, and expectations of leading assays and assay technologies to provide you with the information necessary to select and develop the appropriate assay for the task at hand. The purpose of this report is to help biotechnology and pharmaceutical professionals choose and develop appropriate assays. This Second Edition includes additional content to reflect recent advancements in assay technology. A presentation of the many applications for whole cell assays as well as an expanded discussion of assay multiplexing multiplexing, in communication, technique whereby two or more independent messages, or information-bearing signals, are carried by a single common medium, or channel. has been added. This material recognizes the growing importance of high content, cell-based assays in drug discovery and candidate development. The section on assay methods for ion channels has also been expanded due to the emergence of analytical platforms for high-throughput screening High-throughput screening (HTS), is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Purpose and method of this very significant pharmaceutical target class. Finally, a lengthy appendix devoted to fluorescent proteins has been added that discusses the assay applications and properties of these important "reporter" molecules. Emphasis is on discovery and R&D stages, although these assays are also important for manufacturing and QC. This report will present information on both high-content and high throughput assays. Because it is intended to facilitate the proper choice of assay formats, this report includes many detailed comparisons between the leading possibilities for assays. This report also emphasizes certain, of the more common, assays in biopharma. These include specific discussions of measuring compound quantity, microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. contamination, binding, enzymes, G protein-coupled receptors G protein-coupled receptors (GPCRs), also known as seven transmembrane receptors, 7TM receptors, heptahelical receptors, and G protein linked receptors (GPLR (GPCRs), ion channels, toxicology-pharmacology, and genetic polymorphism polymorphism, of minerals, property of crystallizing in two or more distinct forms. Calcium carbonate is dimorphous (two forms), crystallizing as calcite or aragonite. Titanium dioxide is trimorphous; its three forms are brookite, anatase (or octahedrite), and rutile. . It also includes emphasis on cell-based assay formats, and the most modern assay platforms, featuring miniaturization min·i·a·tur·ize tr.v. min·i·a·tur·ized, min·i·a·tur·iz·ing, min·i·a·tur·iz·es To plan or make on a greatly reduced scale. min and automation. This report presents emerging technologies for assays from the point of view of capabilities, strengths and weaknesses, and expectations for the future. The vocabulary and style of this report assume that the reader has completed at least a bachelor level education in molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller , biochemistry, immunology, or a similar scientific field. Experience or familiarity with assay terminology and technologies are generally not assumed, but an understanding of the business context of the assay program is important for implementing the procedures described herein. This report does contain some technical instructions; in order to be truly useful, many tips for troubleshooting comprise specific materials and methods; however, it is not a laboratory recipe book. Detailed laboratory procedures are mostly left to development by individual labs, in response to local assay goals, policies, and requirements. The information contained here is intended to provide knowledge of assays and assay development that normally accumulate over many years of personal experience with laboratory assay technology. This information does not supersede To obliterate, replace, make void, or useless. Supersede means to take the place of, as by reason of superior worth or right. A recently enacted statute that repeals an older law is said to supersede the prior legislation. requirements imposed by the assay laboratory's corporate, legal, or regulatory environment. While it cannot replace the judgment of experienced laboratory scientists and team managers, it should greatly assist such persons in their duties. Chapter 1: Executive Summary Chapter 2: Introduction. Chapter 3: Common Assays Chapter 4: General Assay Design Chapter 5: Format Chapter 6: Readout (1) A small display device that typically shows only a few digits or a couple of lines of data. (2) Any display screen or panel. (Reporting Format) Chapter 7: Validation Chapter 8: In Vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. Assays Chapter 9: Cell-based Assay Application Areas and Associated Chapter 10: Automation Platforms Chapter 11: Emerging Technologies Chapter 12: Information Management Chapter 13: Appendices Appendix 1: Resources for Detailed Protocols Appendix 2: Checklist for General Assay Development Appendix 3: Microarray Assay Checklist Appendix 4: Vendors Appendix 5: Examples of Troubleshooting Chapter 14: References Table of Exhibits Assays are procedures for detection or quantitation of a specific material within a sample that may contain other interfering materials. In biopharma, the measured material, also called analyte, is usually a drug or drug lead compound, a protein, a gene or gene product, or a particular impurity im·pu·ri·ty n. pl. im·pu·ri·ties 1. The quality or condition of being impure, especially: a. Contamination or pollution. b. Lack of consistency or homogeneity; adulteration. c. or metabolite metabolite, organic compound that is a starting material in, an intermediate in, or an end product of metabolism. Starting materials are substances, usually small and of simple structure, absorbed by the organism as food. . Some assays, called multivariate The use of multiple variables in a forecasting model. or multiplex See multiplexing. , simultaneously report on the presence of more than one material. When it is necessary to treat the sample matrix to facilitate analysis, concentrating the analyte and removing interfering materials, care must be taken to determine the recovery efficiency of the pre-treatment, such as by including an internal standard. While it is theoretically possible to develop an assay with both high sample throughput and high information content, usually one of these is optimized at the expense of the other. High throughput assays are commonly performed as an early screen, before investing in a more definitive high-content procedure. The former primary assays are generally faster and less expensive, and are often more prone to inaccuracies, compared to the latter secondary assays. For more information visit http://www.researchandmarkets.com/reports/c41997 |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion